Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2022

Month: September

Request Number: A-2022-000371

Request Summary: The Health Canada approval letter for Vertex Pharmaceutical's trial to be carried out in Canada: A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes (ClinicalTrials.gov Identifier: NCT04786262).

Disposition: Disclosed in part

Number of pages: 4

Date modified: